OncoSwab is awarded with the DayOneTech Accelerator Prize

We have achieved an extraordinary milestone by being selected as one of only 4 startups awarded the DayOne – Healthcare Innovation Tech Accelerator Prize for groundbreaking medical innovations! This achieves allows us to access to non-dilutive funding, mentorship and be part of the Switzerland Innovation Park in the Basel-Jura area.



DayOne Tech: Shaping the Future of Health

The DayOne Tech Accelerator, managed by Basel Area Business & Innovation, is renowned for its commitment to advancing healthcare innovation. It serves as a bridge between visionary startups and a thriving ecosystem of healthcare stakeholders, including academic institutions, corporations, hospitals, and regulators. This accelerator not only provides funding but also offers invaluable mentorship, networking opportunities, and access to state-of-the-art facilities.

Changing the Game in Cancer Diagnostics

Our selection for DayOne Tech is a testament to our dedication to innovation and patient-centric healthcare solutions. As one of the fortunate few startups chosen to participate in this exclusive program, we will receive up to CHF 100,000 in non-dilutive funding, personalized coaching from world-class experts, and access to a robust network of healthcare partners. This support will be instrumental in advancing our mission to make early cancer detection more accessible and accurate.

Our team is poised to leverage the resources and expertise offered by DayOne Tech to further develop our innovative technology. By refining our diagnostic approach and expanding our reach, we aim to significantly impact the early detection and treatment of cancer, ultimately improving patient outcomes and reducing the burden of this devastating disease.

Looking Ahead

Our participation in DayOne Tech is a remarkable achievement and an exciting chapter in our journey. As we collaborate with industry leaders, researchers, and fellow innovators, the potential for groundbreaking advancements in cancer diagnostics becomes even more promising. We eagerly anticipate the positive impact Oncoswab will have on the future of healthcare.

Stay tuned for updates on our progress within the DayOne Tech Accelerator program as we continue to push the boundaries of cancer diagnostics and shape the future of health.

Scroll to Top